Prior authorization for sickle cell agents (Endari/L-glutamine)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Nevada policy alerts
Know when Blue Cross Blue Shield - Nevada releases new policies or updates existing guidance.
Monitor payer policy activity
Form and prior authorization requirements for L-glutamine (Endari) and related sickle cell therapy requests for members served by Anthem Blue Cross and Blue Shield programs listed; intended for prescribing providers requesting PA for initiation or continuation of therapy.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.